Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Multienzyme complexes or mixtures of enzymes
Patent
1988-02-22
1990-03-13
Huleatt, Jayme A.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Multienzyme complexes or mixtures of enzymes
424 9464, 435212, 435217, 435226, A61K 3762, A61K 37547, C12N 948, C12N 968
Patent
active
049082043
ABSTRACT:
A fibrinolytically active hybrid protein which comprises one chain of a 2-chain protease linked to a chain of a different 2-chain protease, or to the same chain of the same protease, at least one of the chains in the hybrid protein being derived from a fibrinolytically active protease, such that the hybrid protein has a catalytic site essential for fibrinolytic activity which is optionally blocked by a removable blocking group.
REFERENCES:
patent: 4082612 (1978-04-01), Robbins et al.
patent: 4285932 (1981-08-01), Smith
patent: 4507283 (1985-03-01), Smith
patent: 4545988 (1985-10-01), Nakayama et al.
patent: 4600580 (1986-07-01), Smith
Summaria et al., J. Biol Chem, vol. 254, pp. 6811-6814, 1979.
Robbins et al, Biochemistry, vol. 25, pp. 3603-3611, Jun. 1986.
Jackson et al, Biochem. 1982, 21, 6620-6625.
Summaria et al, J. Biol Chem. 251, No. 18, 5810-5813 (1976).
Dodd Ian
Robinson Jeffery H.
Beecham Group p.l.c.
Huleatt Jayme A.
LandOfFree
Reversibly blocked plasmin, t-PA hybrid fibrinolytic enzymes and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reversibly blocked plasmin, t-PA hybrid fibrinolytic enzymes and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reversibly blocked plasmin, t-PA hybrid fibrinolytic enzymes and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-50301